Skip to main content
. 2014 Oct 9;9(12):2044–2051. doi: 10.2215/CJN.03140314

Table 1.

Participant baseline characteristics (n=443)

Variable Self-Rated Health
Good to Excellent Fair to Poor
Participants (n) 207 236
Age (yr) 62.3±12.8 62.2±12.1
Black race 38 (18.3) 64 (27.3)
Women 36 (17.3) 40 (17.0)
Body mass index (mg/kg2) 30.4±6.6 32.4±7.6
Systolic BP (mmHg) 134.3±22.0 136.5±23.6
Current smoking 30 (14.7) 44 (19.4)
Current alcohol use 72 (36.9) 57 (25.7)
Education status
 Less than high school 5 (2.6) 15 (6.9)
 Graduated high school 132 (68.8) 152 (69.7)
 College degree or higher 55 (28.7) 51 (23.4)
Marital status
 Married 77 (39.1) 85 (37.8)
 Never married 43 (21.8) 48 (21.3)
 Widowed 15 (7.6) 20 (8.9)
 Divorced/separated 62 (31.5) 72 (32.0)
Work status
 Employed full-time 27 (19.2) 12 (7.3)
 Employed part-time 17 (12.1) 9 (5.5)
 Unemployed 28 (19.9) 43 (26.2)
 Retired 68 (48.2) 89 (54.3)
 On disability 1 (0.7) 11 (6.7)
Exercise frequency in previous month
 None 28 (21.4) 47 (31.3)
 Once per week or less 38 (29.0) 37 (24.7)
 More than once per week 65 (49.7) 66 (44.0)
Six-minute walk speed (m/s) 0.11±0.03 0.09±0.04
eGFR, CKD-EPI equation (ml/min per 1.73 m2) 38.2±12.2 36.5±13.0
Prevalent disease
 Diabetes mellitus 90 (43.3) 152 (64.7)
 Hypertension 194 (93.3) 234 (99.6)
 Coronary artery disease 80 (38.5) 126 (53.6)
Medication use
 Angiotensin-converting enzyme inhibitor use 100 (48.1) 136 (57.9)
 Angiotensin II receptor blocker use 67 (32.2) 86 (36.6)
 β-Blocker 90 (43.3) 159 (67.7)
 Phosphate binder 26 (12.5) 31 (13.2)
 Statin 127 (61.1) 147 (62.6)
 Antidepressant 58 (27.9) 96 (40.9)
Laboratory measures
 All participants
  Albumin (g/dl) 3.9±0.6 3.7±0.6
  Urine albumin to creatinine ratio (mg/g) 86.3 (13.4, 603.0) 204.9 (25.6, 1016.2)
  Calcium (mg/dl) 9.0±0.8 8.9±0.7
  Cystatin C (mg/dl) 1.9±0.9 2.2±1.2
  Bicarbonate (mmol/L) 24.1±3.5 24.3±3.8
  C-reactive protein (mg/L) 2.1 (0.9, 6.4) 3.2 (1.2, 6.9)
  Uric acid (mg/dl) 7.6±1.8 7.9±1.9
  Hemoglobin (g/dl) 12.9±2.0 12.5±1.8
  Anion gap (mg/dl) 11.4±3.7 11.2±2.3
  Phosphorus (mg/dl) 3.6±0.6 3.8±0.8
Random subset of 210 participants
 Fibroblast growth factor-23 (pg/ml) 61.7 (45.9, 93.5) 65.0 (49.5, 101.5)
 25-Hydroxyvitamin D (ng/ml) 31.2±15.8 27.8±13.6
 Parathyroid hormone (pg/ml) 93.4±69.3 114.1±94.1

Data are presented as the mean±SD, n (%), or median (interquartile range), unless otherwise indicated. CKD-EPI, CKD Epidemiology Collaboration.